KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbCellera Biologics (ABCL) Asset Utilization Ratio (2021 - 2026)

AbCellera Biologics filings provide 6 years of Asset Utilization Ratio readings, the most recent being 0.06 for Q1 2026.

  • Quarterly Asset Utilization Ratio rose 247.9% to 0.06 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.06 through Mar 2026, up 247.9% year-over-year, with the annual reading at 0.06 for FY2025, 173.14% up from the prior year.
  • Asset Utilization Ratio hit 0.06 in Q1 2026 for AbCellera Biologics, up from 0.06 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.38 in Q3 2022 and bottomed at 0.02 in Q1 2025.
  • Average Asset Utilization Ratio over 5 years is 0.11, with a median of 0.03 recorded in 2023.
  • The largest annual shift saw Asset Utilization Ratio tumbled 91.92% in 2023 before it soared 247.9% in 2026.
  • AbCellera Biologics' Asset Utilization Ratio stood at 0.31 in 2022, then tumbled by 91.92% to 0.03 in 2023, then fell by 17.37% to 0.02 in 2024, then soared by 164.43% to 0.06 in 2025, then rose by 7.37% to 0.06 in 2026.
  • Per Business Quant, the three most recent readings for ABCL's Asset Utilization Ratio are 0.06 (Q1 2026), 0.06 (Q4 2025), and 0.03 (Q3 2025).